Fundraising Fox

Darmiyan

YC S17 ↗

San Francisco, US · Founded 2016 · Delaware corporation · 8 employees · 4 known investors

darmiyan.com ↗

Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesArtificial IntelligenceMachine LearningHealth TechDiagnosticsin /company@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (S17)

PKPadideh Kamali-Zare
Padideh Kamali-ZareinFounder
KVKaveh Vejdani
Kaveh VejdaniinFounder/Chief Medical and Technology Officer
ST
Shirai TakehiroDirector

Investors · 4

AAF Management Ltd.Washington
Eisai Innovation, Inc.San Francisco
Y CombinatorSan Francisco · $500K
Thrive CapitalreportedNew York · $500K – $25M

Reported raises · per SEC filings

Form D private placements
▶$3.5MraisedOct 2023 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kaveh VejdaniDirector
  • Takehiro ShiraiDirector
  • Padideh Kamali-ZareExecutive Officer
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.4MraisedApr 2020 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Padideh Kamali-ZareExecutive Officer, Director
  • Shirai TakehiroDirector
  • Kaveh VejdaniExecutive Officer, Director
Offering amount
$9.7M
Amount sold
$6.4M
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news